Cargando…
Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants
G-protein coupled receptors (GPCR) transduce extracellular stimuli into the cell interior and are thus centrally involved in almost all physiological-neuronal processes. This essential function and association with many diseases or pathological conditions explain why GPCRs are one of the priority ta...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832513/ https://www.ncbi.nlm.nih.gov/pubmed/35153771 http://dx.doi.org/10.3389/fphar.2021.826112 |
_version_ | 1784648735431589888 |
---|---|
author | Speck, David Kleinau, Gunnar Meininghaus, Mark Erbe, Antje Einfeldt, Alexandra Szczepek, Michal Scheerer, Patrick Pütter, Vera |
author_facet | Speck, David Kleinau, Gunnar Meininghaus, Mark Erbe, Antje Einfeldt, Alexandra Szczepek, Michal Scheerer, Patrick Pütter, Vera |
author_sort | Speck, David |
collection | PubMed |
description | G-protein coupled receptors (GPCR) transduce extracellular stimuli into the cell interior and are thus centrally involved in almost all physiological-neuronal processes. This essential function and association with many diseases or pathological conditions explain why GPCRs are one of the priority targets in medical and pharmacological research, including structure determination. Despite enormous experimental efforts over the last decade, both the expression and purification of these membrane proteins remain elusive. This is attributable to specificities of each GPCR subtype and the finding of necessary experimental in vitro conditions, such as expression in heterologous cell systems or with accessory proteins. One of these specific GPCRs is the leucine-rich repeat domain (LRRD) containing GPCR 7 (LGR7), also termed relaxin family peptide receptor 1 (RXFP1). This receptor is characterized by a large extracellular region of around 400 amino acids constituted by several domains, a rare feature among rhodopsin-like (class A) GPCRs. In the present study, we describe the expression and purification of RXFP1, including the design of various constructs suitable for functional/biophysical studies and structure determination. Based on available sequence information, homology models, and modern biochemical and genetic tools, several receptor variations with different purification tags and fusion proteins were prepared and expressed in Sf9 cells (small-scale), followed by an analytic fluorescence-detection size-exclusion chromatography (F-SEC) to evaluate the constructs. The most promising candidates were expressed and purified on a large-scale, accompanied by ligand binding studies using surface plasmon resonance spectroscopy (SPR) and by determination of signaling capacities. The results may support extended studies on RXFP1 receptor constructs serving as targets for small molecule ligand screening or structural elucidation by protein X-ray crystallography or cryo-electron microscopy. |
format | Online Article Text |
id | pubmed-8832513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88325132022-02-12 Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants Speck, David Kleinau, Gunnar Meininghaus, Mark Erbe, Antje Einfeldt, Alexandra Szczepek, Michal Scheerer, Patrick Pütter, Vera Front Pharmacol Pharmacology G-protein coupled receptors (GPCR) transduce extracellular stimuli into the cell interior and are thus centrally involved in almost all physiological-neuronal processes. This essential function and association with many diseases or pathological conditions explain why GPCRs are one of the priority targets in medical and pharmacological research, including structure determination. Despite enormous experimental efforts over the last decade, both the expression and purification of these membrane proteins remain elusive. This is attributable to specificities of each GPCR subtype and the finding of necessary experimental in vitro conditions, such as expression in heterologous cell systems or with accessory proteins. One of these specific GPCRs is the leucine-rich repeat domain (LRRD) containing GPCR 7 (LGR7), also termed relaxin family peptide receptor 1 (RXFP1). This receptor is characterized by a large extracellular region of around 400 amino acids constituted by several domains, a rare feature among rhodopsin-like (class A) GPCRs. In the present study, we describe the expression and purification of RXFP1, including the design of various constructs suitable for functional/biophysical studies and structure determination. Based on available sequence information, homology models, and modern biochemical and genetic tools, several receptor variations with different purification tags and fusion proteins were prepared and expressed in Sf9 cells (small-scale), followed by an analytic fluorescence-detection size-exclusion chromatography (F-SEC) to evaluate the constructs. The most promising candidates were expressed and purified on a large-scale, accompanied by ligand binding studies using surface plasmon resonance spectroscopy (SPR) and by determination of signaling capacities. The results may support extended studies on RXFP1 receptor constructs serving as targets for small molecule ligand screening or structural elucidation by protein X-ray crystallography or cryo-electron microscopy. Frontiers Media S.A. 2022-01-28 /pmc/articles/PMC8832513/ /pubmed/35153771 http://dx.doi.org/10.3389/fphar.2021.826112 Text en Copyright © 2022 Speck, Kleinau, Meininghaus, Erbe, Einfeldt, Szczepek, Scheerer and Pütter. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Speck, David Kleinau, Gunnar Meininghaus, Mark Erbe, Antje Einfeldt, Alexandra Szczepek, Michal Scheerer, Patrick Pütter, Vera Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title | Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title_full | Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title_fullStr | Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title_full_unstemmed | Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title_short | Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants |
title_sort | expression and characterization of relaxin family peptide receptor 1 variants |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832513/ https://www.ncbi.nlm.nih.gov/pubmed/35153771 http://dx.doi.org/10.3389/fphar.2021.826112 |
work_keys_str_mv | AT speckdavid expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT kleinaugunnar expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT meininghausmark expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT erbeantje expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT einfeldtalexandra expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT szczepekmichal expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT scheererpatrick expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants AT puttervera expressionandcharacterizationofrelaxinfamilypeptidereceptor1variants |